Omega Healthcare Investors - OHI Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omega Healthcare Investors in the last year. There are currently 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" OHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OHI, but not buy additional shares or sell existing shares.
View OHI analyst ratings or view top-rated stocks.

8 brokers have issued 12 month target prices for Omega Healthcare Investors' stock. Their OHI share price forecasts range from $28.00 to $35.00. On average, they predict the company's stock price to reach $31.33 in the next twelve months. This suggests a possible upside of 7.2% from the stock's current price.
View analysts price targets for OHI or view top-rated stocks among Wall Street analysts.

Omega Healthcare Investors' stock was trading at $29.59 at the start of the year. Since then, OHI stock has decreased by 1.2% and is now trading at $29.24.
View the best growth stocks for 2022 here.

Omega Healthcare Investors saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 17,580,000 shares, an increase of 18.1% from the October 31st total of 14,890,000 shares. Based on an average daily trading volume, of 2,040,000 shares, the short-interest ratio is currently 8.6 days. Currently, 7.5% of the company's stock are sold short.
View Omega Healthcare Investors' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our OHI earnings forecast.

Omega Healthcare Investors, Inc. (NYSE:OHI) posted its earnings results on Monday, August, 1st. The real estate investment trust reported $0.38 earnings per share for the quarter, missing analysts' consensus estimates of $0.73 by $0.35. The real estate investment trust earned $207.54 million during the quarter, compared to the consensus estimate of $220.06 million. Omega Healthcare Investors had a net margin of 42.17% and a trailing twelve-month return on equity of 10.32%. The firm's revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the company posted $0.85 earnings per share.

Omega Healthcare Investors announced a quarterly dividend on Friday, October 21st. Shareholders of record on Tuesday, November 1st will be paid a dividend of $0.67 per share on Tuesday, November 15th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 9.17%. The ex-dividend date is Monday, October 31st.
Read our dividend analysis for OHI.

Omega Healthcare Investors (NYSE:OHI) pays an annual dividend of $2.68 per share and currently has a dividend yield of 8.95%. OHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 154.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, OHI will have a dividend payout ratio of 87.58% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for OHI.

3 employees have rated Omega Healthcare Investors Chief Executive Officer C. Taylor Pickett on Glassdoor.com. C. Taylor Pickett has an approval rating of 56% among the company's employees. This puts C. Taylor Pickett in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Verizon Communications (VZ), Energy Transfer (ET), Realty Income (O), Cisco Systems (CSCO), AbbVie (ABBV), Annaly Capital Management (NLY), New Residential Investment (NRZ) and Pfizer (PFE).

Omega Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "OHI."

Omega Healthcare Investors' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (14.59%), BlackRock Inc. (11.78%), State Street Corp (5.51%), Bank of New York Mellon Corp (2.34%), Dimensional Fund Advisors LP (1.37%) and Federated Hermes Inc. (1.20%). Insiders that own company stock include Burke W Whitman, Burke W Whitman, C Taylor Pickett, Craig R Callen, Daniel J Booth, Kapila K Anand, Michael Ritz, Neal Ballew, Robert O Stephenson and Steven J Insoft.
View institutional ownership trends.

Shares of OHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OHI stock can currently be purchased for approximately $29.24.

Omega Healthcare Investors (NYSE:OHI) has a market capitalization of $6.85 billion and generates $1.06 billion in revenue each year. The real estate investment trust earns $416.74 million in net income (profit) each year or $1.74 on an earnings per share basis.

Omega Healthcare Investors' mailing address is 303 International Circle Suite 200, HUNT VALLEY MD, 21030. The official website for the company is www.omegahealthcare.com. The real estate investment trust can be reached via phone at (410) 427-1700, via email at mgourmand@omegahealthcare.com, or via fax at 410-427-8800.